TY - JOUR
T1 - Impact of SARS-CoV-2 viral load and duration of symptoms before hospital admission on the mortality of hospitalized COVID-19 patients
AU - COVID-19-researcher group
AU - Rico-Caballero, Verónica
AU - Fernández, Mariana
AU - Hurtado, Juan C.
AU - Marcos, M. Angeles
AU - Cardozo, Celia
AU - Albiach, Laia
AU - Agüero, Daiana
AU - Ambrosioni, Juan
AU - Bodro, Marta
AU - Chumbita, Mariana
AU - De la Mora, Lorena
AU - Garcia-Pouton, Nicole
AU - Gonzalez-Cordón, Ana
AU - Dueñas, Gerard
AU - Hernandez-Meneses, Marta
AU - Inciarte, Alexy
AU - Laguno, Montse
AU - Leal, Lorna
AU - Macaya, Irene
AU - Martínez, Miguel J.
AU - Cuesta, Genoveva
AU - Meira, Fernanda
AU - Morata, Laura
AU - Puerta-Alcalde, Pedro
AU - Rojas, John
AU - Torres, Berta
AU - Castro, Pedro
AU - Muñoz, Jose
AU - Mensa, Josep
AU - Martínez, José Antonio
AU - Sanjuan, Gemma
AU - Vila, Jordi
AU - García, Felipe
AU - Garcia-Vidal, Carolina
AU - Soriano, Alex
AU - Blanco, J. L.
AU - Mallolas, J.
AU - Martínez, E.
AU - Martínez, M.
AU - Miró, J. M.
AU - Moreno, A.
AU - Del Rio, A.
AU - Solá, M.
AU - Torres, M.
AU - Ugarte, A.
AU - Cozar-Lladó, A.
AU - Linares, L.
AU - Tellez, A.
AU - Fernandez, S.
AU - Nicolas, J. M.
N1 - Publisher Copyright:
© 2022, The Author(s), under exclusive licence to Springer-Verlag GmbH Germany.
PY - 2022/10
Y1 - 2022/10
N2 - Purpose: Assess the impact of viral load estimated by cycle threshold (Ct) of reverse transcription real time-polymerase chain reaction (rRT-PCR) and the days from symptoms onset on mortality in hospitalized patients with COVID19. Methods: Retrospective observational study of 782 patients with a positive rRT-PCR from a nasopharyngeal swab was performed within the first 24 h from admission. Demographic data, clinical manifestations and laboratory parameters were collected. Uni- and multivariate analyses were performed to identify factors associated with mortality at 60 days. Results: Ct was divided into three groups and the mortality rate decreased from 27.3 to 20.7% and 9.8% for Ct values of ≤ 20, 21–25 and > 25, respectively (P = 0.0001). The multivariate analysis identified as predictors of mortality, a Ct value < 20 (OR 3.13, CI 95% 1.38–7.10), between 21–25 (OR 2.47, CI 95% 1.32–4.64) with respect to a Ct value > 25. Days from symptoms onset is a variable associated with mortality as well (DSOA) ≤ 6 (OR 1.86, CI 95% 1.00–3.46), among other factors. Patients requiring hospital admission within 6 DSOA with a Ct value ≤ 25 had the highest mortality rate (28%). Conclusions: The inclusion of Ct values and DSOA in the characterization of study populations could be a useful tool to evaluate the efficacy of antivirals.
AB - Purpose: Assess the impact of viral load estimated by cycle threshold (Ct) of reverse transcription real time-polymerase chain reaction (rRT-PCR) and the days from symptoms onset on mortality in hospitalized patients with COVID19. Methods: Retrospective observational study of 782 patients with a positive rRT-PCR from a nasopharyngeal swab was performed within the first 24 h from admission. Demographic data, clinical manifestations and laboratory parameters were collected. Uni- and multivariate analyses were performed to identify factors associated with mortality at 60 days. Results: Ct was divided into three groups and the mortality rate decreased from 27.3 to 20.7% and 9.8% for Ct values of ≤ 20, 21–25 and > 25, respectively (P = 0.0001). The multivariate analysis identified as predictors of mortality, a Ct value < 20 (OR 3.13, CI 95% 1.38–7.10), between 21–25 (OR 2.47, CI 95% 1.32–4.64) with respect to a Ct value > 25. Days from symptoms onset is a variable associated with mortality as well (DSOA) ≤ 6 (OR 1.86, CI 95% 1.00–3.46), among other factors. Patients requiring hospital admission within 6 DSOA with a Ct value ≤ 25 had the highest mortality rate (28%). Conclusions: The inclusion of Ct values and DSOA in the characterization of study populations could be a useful tool to evaluate the efficacy of antivirals.
KW - COVID-19
KW - Ct value
KW - Days of symptoms
KW - Mortality
KW - Viral load
UR - https://www.scopus.com/pages/publications/85131872956
U2 - 10.1007/s15010-022-01833-8
DO - 10.1007/s15010-022-01833-8
M3 - Article
C2 - 35562568
AN - SCOPUS:85131872956
SN - 0300-8126
VL - 50
SP - 1321
EP - 1328
JO - Infection
JF - Infection
IS - 5
ER -